For: | Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Buurman R, Skawran B, Lehmann U. hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma. World J Gastroenterol 2017; 23(9): 1568-1575 [PMID: 28321157 DOI: 10.3748/wjg.v23.i9.1568] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i9/1568.htm |
Number | Citing Articles |
1 |
Marie Boyle, Jelena Mann. WITHDRAWN: Epigenetics in Chronic Liver Disease. Journal of Hepatology 2017; doi: 10.1016/j.jhep.2017.08.016
|
2 |
Jing Yuan, Rui Dong, Fei Liu, Lijun Zhan, Yu Liu, Jun Wei, Ninghua Wang. The miR‑183/182/96 cluster functions as a potential carcinogenic factor and prognostic factor in kidney renal clear cell carcinoma. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7221
|
3 |
Shinichi Umeda, Mitsuro Kanda, Yasuhiro Kodera. Recent advances in molecular biomarkers for patients with hepatocellular carcinoma. Expert Review of Molecular Diagnostics 2019; 19(8): 725 doi: 10.1080/14737159.2019.1638254
|
4 |
Yaqian Niu, Fang Liu, Xiuyue Wang, Yuling Chang, Yanmei Song, Huiyuan Chu, Shisan Bao, Che Chen. miR-183-5p Promotes HCC Migration/Invasion via Increasing Aerobic Glycolysis. OncoTargets and Therapy 2021; : 3649 doi: 10.2147/OTT.S304117
|
5 |
Xingxing Zhao, Yongping Jia, Huanzhen Chen, Hongmei Yao, Wenlin Guo. Plasma‑derived exosomal miR‑183 associates with protein kinase activity and may serve as a novel predictive biomarker of myocardial ischemic injury. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7555
|
6 |
Bashdar Mahmud Hussen, Hazha Jamal Hidayat, Abbas Salihi, Dana K. Sabir, Mohammad Taheri, Soudeh Ghafouri-Fard. MicroRNA: A signature for cancer progression. Biomedicine & Pharmacotherapy 2021; 138: 111528 doi: 10.1016/j.biopha.2021.111528
|
7 |
Priyanka Kulkarni, Pritha Dasgupta, Nadeem S. Bhat, Varahram Shahryari, Marisa Shiina, Yutaka Hashimoto, Shahana Majid, Guoren Deng, Sharanjot Saini, Z. Laura Tabatabai, Soichiro Yamamura, Yuichiro Tanaka, Rajvir Dahiya. Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished MALAT-1 Expression. Molecular Cancer Research 2018; 16(11): 1750 doi: 10.1158/1541-7786.MCR-17-0762
|
8 |
Ming Li, Da-Ming Xu, Shu-Bin Lin, Zheng-Liang Yang, Teng-Yu Xu, Jin-Huan Yang, Ze-Xin Lin, Ze-Kai Huang, Jun Yin. Transcriptional expressions of hsa-mir-183 predicted target genes as independent indicators for prognosis in bladder urothelial carcinoma. Aging 2022; 14(9): 3782 doi: 10.18632/aging.204040
|
9 |
Meiyue Liu, Jiarui Yu, Dan Wang, Yi Niu, Siyuan Chen, Peng Gao, Zhao Yang, Huan Wang, Jie Zhang, Chao Zhang, Yue Zhao, Wanning Hu, Guogui Sun. Epigenetically Upregulated MicroRNA-602 Is Involved in a Negative Feedback Loop with FOXK2 in Esophageal Squamous Cell Carcinoma. Molecular Therapy 2019; 27(10): 1796 doi: 10.1016/j.ymthe.2019.07.006
|
10 |
Wenbiao Chen, Donge Tang, Dongxin Tang, Yong Dai. Epigenetic silencing of ZIC4 contributes to cancer progression in hepatocellular carcinoma. Cell Death & Disease 2020; 11(10) doi: 10.1038/s41419-020-03109-1
|
11 |
Sumadi Lukman Anwar, Britta Hasemeier, Elisa Schipper, Arndt Vogel, Hans Kreipe, Ulrich Lehmann, Matias A. Avila. LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype. PLOS ONE 2019; 14(5): e0216374 doi: 10.1371/journal.pone.0216374
|
12 |
Jian Sun, Lijun Liu, Huilian Zou, Wei Yu. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183. Yonsei Medical Journal 2019; 60(10): 905 doi: 10.3349/ymj.2019.60.10.905
|
13 |
Zhuojun Zheng, Xiao Zheng, Yuandong Zhu, Xiaoyan Gu, Weiying Gu, Xiaobao Xie, Wenwei Hu, Jingting Jiang. miR-183-5p Inhibits Occurrence and Progression of Acute Myeloid Leukemia via Targeting Erbin. Molecular Therapy 2019; 27(3): 542 doi: 10.1016/j.ymthe.2019.01.016
|